Radiation Oncology Program

Radiation Oncology Symposium

Date:	Thursday, January 5, 2012
Time:	12:30 p.m. to 4:50 p.m. with reception to follow
Location:	University of Maryland Southern Management Corporation Campus Center 621 W. Lombard Street Baltimore, MD 21201

About the Course:

View the Course Agenda

The Radiation Oncology Symposium Best of 2011 will provide the attendees with the new changes in technology and treatment modalities that have occurred in the past year. This includes the latest developments in treating the following cancers: genitourinary, head & neck, central nervous system, gastrointestinal, breast, thoracic and lymphoma.

Target Audience:

The Radiation Oncology Symposium Best of 2011 is designed for radiation oncologists, medical physicists, radiation therapists, medical oncologists, hematologists, nurse practitioners, dosimitrists, physician assistants and nurses.

Learning Objectives:

Upon completion of this activity, participants should be able to:

Describe current treatment options for various malignancies.
Assess important studies and clinical trials in radiation oncology.
Review the role and indications for radiation therapy.

Cost: $125.00

Advance registration is required. There will be FREE garage parking available. If you have any questions or would like more information, please contact Duane Henderson at (410) 328-6928 or dhenderson1@umm.edu.

For More Information:

Faculty and staff may also fax their registration forms to 410-328-6911, or mail them directly to Duane Henderson to register:

Department of Radiation Oncology
University of Maryland Medical Center
Attn: Duane Henderson
22 S. Greene Street
Baltimore, MD 21201

CME Sponsorship: Sponsored by the University of Maryland School of Medicine.

Accreditation: The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement: The University of Maryland School of Medicine designates this Live activity for a maximum of 4 AMA PRA Category 1 CreditsT. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ADA Statement: If you required special accommodations to attend or participate in this CME activity, please provide information about your requirements to Project Coordinator, Duane Henderson at (410) 328-6928 at least five business days in advance of the activity.

Disclosure of Commercial Relationships: It is the policy of the University of Maryland School of Medicine (UMSOM) to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, all persons in a position to control activity content must disclose their financial relationships with commercial interests relevant to the content of the CME activity. Any conflicts of interest identified must be resolved prior to the educational activity. Specific information regarding the existence or non-existence of commercial relationships among all those in a position to control activity content will be presented to participants in course materials prior to the start of the educational activity.

Discussion of Off-Label or Investigational Uses of Products: Presentations in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. The audience is advised to consult the full prescribing information of all drugs or devices prior to use. Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with the applicable law.

UMSOM requires that all contributors disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.

Disclaimer: This CME activity is designed for use by healthcare professionals for educational purposes only. Information and opinions offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information. While UMSOM makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others.

Acknowledgment of Commercial Support: UMSOM will execute educational grant agreements with all commercial interests providing financial or in-kind support for the activity. A complete listing of these commercial entities will be provided to participants in course materials prior to the start of the educational activity.

Course Director:
William F. Regine, M.D.
Isadore and Fannie Schneider Foxman Chair and Professor of Radiation Oncology
University of Maryland School of Medicine

This page was last updated on: November 16, 2011.